Patent Foramen Ovale (PFO)Learn More
Artrial Septal Defect (ASD)Learn More
Ventricular Septal Defect (VSD)Learn More
NMT Medical is a pioneer in the field of non-surgical repair of structural heart defects in children and adults. Over 30,000 septal defects have been closed using our proprietary technology.
Recently Completed Trials:MIST (Migraine Intervention with STARFlex® Technology) defined the “treatment effect” of closing a patent foramen ovale (PFO) in certain patients suffering from refractory migraine headache.
BEST (BioSTAR® Evaluation Study) demonstrated closure rates for the worlds first bioabsorbable septal repair implant to be significantly better than competing technologies.
Ongoing Clinical trials:CLOSURE I (enrollment completed) - compares current medical therapy to PFO closure in patients who have experienced a stroke or TIA.
MIST III - is a follow-on study to the completed MIST trial.
10/29/2009 NMT Medical Announces Third-Quarter 2009 Financial Results
10/9/2009 NMT Medical to Release Third-Quarter 2009 Financial Results on October 29
9/16/2009 NMT Medical to Accelerate CLOSURE I Data Analysis Timing
8/11/2009 NMT Medical Announces Listing Transfer to The NASDAQ Capital Market from The NASDAQ Global Market
8/4/2009 NMT Medical Announces Second-Quarter 2009 Financial Results